95.21MMarket Cap-0.65P/E (TTM)
17.010High15.500Low72.82KVolume16.900Open16.850Pre Close1.18MTurnover1.55%Turnover RatioLossP/E (Static)5.76MShares39.50052wk High-1.05P/B77.45MFloat Cap6.50052wk Low--Dividend TTM4.69MShs Float1638.998Historical High--Div YieldTTM8.96%Amplitude4.965Historical Low16.206Avg Price1Lot Size
Atara Biotherapeutics Stock Forum
📊⚡️📊
Updated Clinical Results: ALLELE study, a pivotal Phase 3 clinical trial evaluating tabelecleucel (tab-cel) in patients with Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) after failure of rituximab or rituximab and chemotherapy.
The study demonstrated a statistically significant overall response rate (ORR) of 49%, with a median duration of response of 23 months ano nedian overall survival of 18.4 months. The sa...
📊⚡️📊
Should see increased acitivity soon as all these large investors have interest in this comp...
No comment yet